Cerevel Therapeutics Holdings Stock Revenue
Cerevel Therapeutics Holdings fundamentals help investors to digest information that contributes to Cerevel Therapeutics' financial success or failures. It also enables traders to predict the movement of Cerevel Stock. The fundamental analysis module provides a way to measure Cerevel Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cerevel Therapeutics stock.
Cerevel |
Cerevel Therapeutics Holdings Company Revenue Analysis
Cerevel Therapeutics' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, Cerevel Therapeutics Holdings reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Cerevel Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cerevel Therapeutics' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cerevel Therapeutics could also be used in its relative valuation, which is a method of valuing Cerevel Therapeutics by comparing valuation metrics of similar companies.Cerevel Therapeutics is currently under evaluation in revenue category among its peers.
Cerevel Fundamentals
| Return On Equity | -0.92 | |||
| Return On Asset | -0.3 | |||
| Current Valuation | 7.71 B | |||
| Shares Outstanding | 182.2 M | |||
| Shares Owned By Insiders | 15.32 % | |||
| Shares Owned By Institutions | 85.12 % | |||
| Number Of Shares Shorted | 5.98 M | |||
| Price To Earning | (0.26) X | |||
| Price To Book | 14.51 X | |||
| EBITDA | (441.64 M) | |||
| Net Income | (432.84 M) | |||
| Cash And Equivalents | 531.21 M | |||
| Cash Per Share | 3.58 X | |||
| Total Debt | 480.78 M | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 9.52 X | |||
| Book Value Per Share | 3.10 X | |||
| Cash Flow From Operations | (342.3 M) | |||
| Short Ratio | 2.37 X | |||
| Earnings Per Share | (2.73) X | |||
| Target Price | 43.4 | |||
| Number Of Employees | 355 | |||
| Beta | 1.41 | |||
| Market Capitalization | 8.19 B | |||
| Total Asset | 1.24 B | |||
| Retained Earnings | (1.4 B) | |||
| Working Capital | 914.76 M | |||
| Current Asset | 9.77 M | |||
| Current Liabilities | 5.22 M | |||
| Net Asset | 1.24 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Consideration for investing in Cerevel Stock
If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |